The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis

Behavioural Brain Research

Volumn 270, Issue , 2014, Pages 179-195

  Too, Lay Khoon ^a   McQuillan, James A ^a   Ball, Helen J ^a   Kanai, Masaaki ^b   Nakamura, Toshikazu ^c   Funakoshi, Hiroshi ^b   McGregor, Iain S ^b   Hunt, Nicholas H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Indoleamine dioxygenase 1; IntelliCage; Kynurenine pathway; Neuroinflammation; Neurological sequelae; Pneumococcal meningitis

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE DIOXYGENASE 1; KYNURENINE; TRYPTOPHAN 2,3 DIOXYGENASE; TRYPTOPHAN DIOXYGENASE 2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEFTRIAXONE; IDO1 PROTEIN, MOUSE; IDO2 PROTEIN, MOUSE; TRYPTOPHAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; DIURNAL HYPOACTIVITY; ENZYME ACTIVITY; FEMALE; GENE INACTIVATION; HYPERACTIVITY; HYPOACTIVITY; MALE; MORTALITY; MOUSE; NEUROMODULATION; NOCTURNAL HYPERACTIVITY; NONHUMAN; PATHOGENESIS; PHOTOSTIMULATION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; STIMULUS RESPONSE; TRYPTOPHAN METABOLISM; WILD TYPE; ANIMAL; C57BL MOUSE; COGNITION; DEFICIENCY; DRUG EFFECTS; KNOCKOUT MOUSE; MENINGITIS, PNEUMOCOCCAL; METABOLISM; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; TRYPTOPHAN;

EID: 84901506605     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.018     Document Type: Article

References (59)

1. Scarborough M., Thwaites G.E. The diagnosis and management of acute bacterial meningitis in resource-poor settings. Lancet Neurol 2008, 7:637-648.
2. Casado-Flores J., Aristegui J., de Liria C.R., Martinon J.M., Fernandez C. Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur J Pediatr 2006, 165:285-289.
3. Weisfelt M., van de Beek D., Spanjaard L., Reitsma J.B., de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006, 5:123-129.
4. Christie D., Viner R.M., Knox K., Coen P.G., Wang H., El Bashir H., et al. Long-term outcomes of pneumococcal meningitis in childhood and adolescence. Eur J Pediatr 2011, 170:997-1006.
5. Ostergaard C., Konradsen H.B., Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005, 5:93.
6. Koedel U., Klein M., Pfister H.W. New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 2010, 23:217-223.
7. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002, 2:721-736.
8. Nelson R.P. Bacterial meningitis and inflammation. Curr Opin Neurol 2006, 19:369-373.
9. Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A., Lowry C.A. Tryptophan metabolism in the central nervous system: medical implications. Exp Rev Mol Med 2006, 8:1-27.
10. Heyes M.P., Saito K., Crowley J.S., Davis L.E., Demitrack M.A., Der M., et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992, 115(Pt 5):1249-1273.
11. Heyes M.P., Saito K., Milstien S., Schiff S.J. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J Neurol Sci 1995, 133:112-118.
12. Bellac C.L., Coimbra R.S., Christen S., Leib S.L. Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiol Dis 2006, 24:395-402.
13. Coutinho L.G., Bellac C.L., Grandgirard D., Wittwer M., Coimbra R.S., Christen S., et al. Assessment of tryptophan metabolism and cytokine profile in cerebrospinal fluid samples from patients with bacterial meningitis 2007, European Society of Clinical Microbiology and Infectious Diseases, ICC, Munich, Germany.
14. Leib S.L., Kim Y.S., Ferriero D.M., Tauber M.G. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996, 173:166-171.
15. Plangar I., Majlath Z., Vecsei L. Kynurenines in cognitive functions: their possible role in depression. Neuropsychopharmacol Hung 2012, 14:239-244.
16. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
17. Vecsei L., Szalardy L., Fulop F., Toldi J. Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 2013, 12:64-82.
18. Too L.K., Ball H.J., McGregor I.S., Hunt N.H. The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav Immun 2014.
19. Too L.K., Mitchell A.J., Yau B., Ball H.J., McGregor I.S., Hunt N.H. Interleukin-18 deficiency and its long-term behavioural and cognitive impacts in a murine model of pneumococcal meningitis. Behav Brain Res 2014.
20. Kanai M., Funakoshi H., Takahashi H., Hayakawa T., Mizuno S., Matsumoto K., et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2009, 2:8.
21. Mellor A.L., Baban B., Chandler P., Marshall B., Jhaver K., Hansen A., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003, 171:1652-1655.
22. Too L.K., Ball H.J., McGregor I.S., Hunt N.H. A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine pneumococcal meningitis. Brain Behav Immun 2014, 35:107-124.
23. Galsworthy M.J., Amrein I., Kuptsov P.A., Poletaeva I.I., Zinn P., Rau A., et al. A comparison of wild-caught wood mice and bank voles in the Intellicage: assessing exploration, daily activity patterns and place learning paradigms. Behav Brain Res 2005, 157:211-217.
24. Mechan A.O., Wyss A., Rieger H., Mohajeri M.H. A comparison of learning and memory characteristics of young and middle-aged wild-type mice in the IntelliCage. J Neurosci Methods 2009, 180:43-51.
25. Rudenko O., Tkach V., Berezin V., Bock E. Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage. Behav Brain Res 2009, 203:188-199.
26. Krackow S., Vannoni E., Codita A., Mohammed A.H., Cirulli F., Branchi I., et al. Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage. Genes Brain Behav 2010, 9:722-731.
27. Niewoehner B., Single F.N., Hvalby O., Jensen V., Meyer zum Alten Borgloh S., Seeburg P.H., et al. Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci 2007, 25:837-846.
28. Hornak J., O'Doherty J., Bramham J., Rolls E.T., Morris R.G., Bullock P.R., et al. Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 2004, 16:463-478.
29. Free S.L., Li L.M., Fish D.R., Shorvon S.D., Stevens J.M. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 1996, 37:400-405.
30. Focke N.K., Kallenberg K., Mohr A., Djukic M., Nau R., Schmidt H. Distributed, limbic gray matter atrophy in patients after bacterial meningitis. AJNR Am J Neuroradiol 2013, 34:1164-1167.
31. Mook-Kanamori B.B., Geldhoff M., van der Poll T., van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011, 24:557-591.
32. Barichello T., Generoso J.S., Collodel A., Moreira A.P., Almeida S.M. Pathophysiology of acute meningitis caused by Streptococcus pneumoniae and adjunctive therapy approaches. Arq Neuropsiquiatr 2012, 70:366-372.
33. van der Flier M., Geelen S.P., Kimpen J.L., Hoepelman I.M., Tuomanen E.I. Reprogramming the host response in bacterial meningitis: how best to improve outcome. Clin Microbiol Rev 2003, 16:415-429.
34. Axelrod B.N., Goldman R.S., Heaton R.K., Curtiss G., Thompson L.L., Chelune G.J., et al. Discriminability of the Wisconsin Card Sorting Test using the standardization sample. J Clin Exp Neuropsychol 1996, 18:338-342.
35. Wahlsten D., Metten P., Phillips T.J., Boehm S.L., Burkhart-Kasch S., Dorow J., et al. Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 2003, 54:283-311.
36. Wahlsten D., Rustay N.R., Metten P., Crabbe J.C. In search of a better mouse test. Trends Neurosci 2003, 26:132-136.
37. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
38. Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin 2006, 24:441-460.
39. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 2001, 933:222-234.
40. Dantzer R., Bluthe R.M., Gheusi G., Cremona S., Laye S., Parnet P., et al. Molecular basis of sickness behavior. Ann NY Acad Sci 1998, 856:132-138.
41. Bellac C.L., Coimbra R.S., Christen S., Leib S.L. Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis. J Neuropathol Exp Neurol 2010.
42. Salazar A., Gonzalez-Rivera B.L., Redus L., Parrott J.M., O'Connor J.C. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 2012, 62:202-209.
43. O'Connor J.C., Lawson M.A., Andre C., Briley E.M., Szegedi S.S., Lestage J., et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 2009, 182:3202-3212.
44. Barichello T., Generoso J.S., Simoes L.R., Elias S.G., Tashiro M.H., Dominguini D., et al. Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis. Transl Res 2013.
45. Marvel C.L., Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 2004, 162:390-397.
46. Mineur Y.S., Picciotto M.R., Sanacora G. Antidepressant-like effects of ceftriaxone in male C57BL/6J mice. Biol Psychiatry 2007, 61:250-252.
47. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009, 14:511-522.
48. Baran H., Kepplinger B., Herrera-Marschitz M., Stolze K., Lubec G., Nohl H. Increased kynurenic acid in the brain after neonatal asphyxia. Life Sci 2001, 69:1249-1256.
49. Braidy N., Grant R., Adams S., Brew B.J., Guillemin G.J. Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 2009, 16:77-86.
50. Stone T.W., Behan W.M., Jones P.A., Darlington L.G., Smith R.A. The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines. J Alzheimers Dis 2001, 3:355-366.
51. Sas K., Robotka H., Toldi J., Vecsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007, 257:221-239.
52. Guidetti P., Schwarcz R. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 1999, 11:3857-3863.
53. Behan W.M., Stone T.W. Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br J Pharmacol 2002, 135:1435-1442.
54. Zinger A., Barcia C., Herrero M.T., Guillemin G.J. The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease. Parkinsons Dis 2011, 2011:716859.
55. Silber B.Y., Schmitt J.A. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev 2010, 34:387-407.
56. Hoffmann O., Keilwerth N., Bille M.B., Reuter U., Angstwurm K., Schumann R.R., et al. Triptans reduce the inflammatory response in bacterial meningitis. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 2002, 22:988-996.
57. Forrest C.M., Mackay G.M., Stoy N., Egerton M., Christofides J., Stone T.W., et al. Tryptophan loading induces oxidative stress. Free Radic Res 2004, 38:1167-1171.
58. Matsuo N., Takao K., Nakanishi K., Yamasaki N., Tanda K., Miyakawa T. Behavioral profiles of three C57BL/6 substrains. Front Behav Neurosci 2010, 4:29.
59. Codita A., Mohammed A.H., Willuweit A., Reichelt A., Alleva E., Branchi I., et al. Effects of spatial and cognitive enrichment on activity pattern and learning performance in three strains of mice in the IntelliMaze. Behav Genet 2011.